Cancer research has seen explosive development exploring deep learning (DL) techniques for analysing magnetic resonance imaging (MRI) images for predicting brain tumours. We have observed a substantial gap in explanation, interpretability, and high accuracy for DL models. Consequently, we propose an explanation-driven DL model by utilising a convolutional neural network (CNN), local interpretable model-agnostic explanation (LIME), and Shapley additive explanation (SHAP) for the prediction of discrete subtypes of brain tumours (meningioma, glioma, and pituitary) using an MRI image dataset. Unlike previous models, our model used a dual-input CNN approach to prevail over the classification challenge with images of inferior quality in terms of noise and metal artifacts by adding Gaussian noise. Our CNN training results reveal 94.64% accuracy as compared to other state-of-the-art methods. We used SHAP to ensure consistency and local accuracy for interpretation as Shapley values examine all future predictions applying all possible combinations of inputs. In contrast, LIME constructs sparse linear models around each prediction to illustrate how the model operates in the immediate area. Our emphasis for this study is interpretability and high accuracy, which is critical for realising disparities in predictive performance, helpful in developing trust, and essential in integration into clinical practice. The proposed method has a vast clinical application that could potentially be used for mass screening in resource-constraint countries.

Introduction: Diabetes is considered one of the leading healthcare concerns affecting millions worldwide. Taking appropriate action at the earliest stages of the disease depends on early diabetes prediction and identification. To support healthcare providers for better diagnosis and prognosis of diseases, machine learning has been explored in the healthcare industry in recent years.Methods: To predict diabetes, this research has conducted experiments on five boosting algorithms on the Pima diabetes dataset. The dataset was obtained from the University of California, Irvine (UCI) machine learning repository, which contains several important clinical features. Exploratory data analysis was used to identify the characteristics of the dataset. Moreover, upsampling, normalisation, feature selection, and hyperparameter tuning were employed for predictive analytics.Results: The results were analysed using various statistical/machine learning metrics and k-fold cross-validation techniques. Gradient boosting achieved the greatest accuracy rate of 92.85% among all the classifiers. Precision, recall, f1-score, and receiver operating characteristic (ROC) curves were used to further validate the model.Discussion: The suggested model outperformed the current studies in terms of prediction accuracy, demonstrating its applicability to other diseases with similar predicate indications.

The cultivation of most crops depends upon the regional weather conditions. So, the analysis of the agro-climatic conditions of a zone contributes significantly to deciding the right crop for the right land in the right season to obtain a better yield. Machine learning algorithms facilitate this process to a great extent for better results. In this paper, the authors proposed an ML-based crop selection model based on the weather conditions and soil parameters, collectively. Weather analysis is done using LSTM RNN and the process of crop selection is completed using Random Forest Classifier. This model gives better results for weather prediction in comparison to ANN. With LSTM RNN, the RMSE observed in Min. Temp. prediction is 5.023%, Max. Temp. Prediction is 7.28%, and Rainfall Prediction is 8.24%. In the second phase, the Random Forest Classifier showed 97.235% accuracy for crop selection, 96.437% accuracy in predicting resource dependency, and 97.647 accuracies in giving the appropriate sowing time for the crop. The model construction time taken with a random forest classifier using mentioned data size is 5.34 s. The authors also suggested the future research direction to further improve this work.

Epigenome-wide association studies (EWASs) have become increasingly popular for studying DNA methylation (DNAm) variations in complex diseases. The Illumina methylation arrays provide an economical, high-throughput and comprehensive platform for measuring methylation status in EWASs. A number of software tools have been developed for identifying disease-associated differentially methylated regions (DMRs) in the epigenome. However, in practice, we found these tools typically had multiple parameter settings that needed to be specified and the performance of the software tools under different parameters was often unclear. To help users better understand and choose optimal parameter settings when using DNAm analysis tools, we conducted a comprehensive evaluation of 4 popular DMR analysis tools under 60 different parameter settings. In addition to evaluating power, precision, area under precision-recall curve, Matthews correlation coefficient, F1 score and type I error rate, we also compared several additional characteristics of the analysis results, including the size of the DMRs, overlap between the methods and execution time. The results showed that none of the software tools performed best under their default parameter settings, and power varied widely when parameters were changed. Overall, the precision of these software tools were good. In contrast, all methods lacked power when effect size was consistent but small. Across all simulation scenarios, comb-p consistently had the best sensitivity as well as good control of false-positive rate.

DNA microarray is a powerful technology that can simultaneously determine the levels of thousands of transcripts (generated, for example, from genes/miRNAs) across different experimental conditions or tissue samples. The motto of differential expression analysis is to identify the transcripts whose expressions change significantly across different types of samples or experimental conditions. A number of statistical testing methods are available for this purpose. In this paper, we provide a comprehensive survey on different parametric and non-parametric testing methodologies for identifying differential expression from microarray data sets. The performances of the different testing methods have been compared based on some real-life miRNA and mRNA expression data sets. For validating the resulting differentially expressed miRNAs, the outcomes of each test are checked with the information available for miRNA in the standard miRNA database PhenomiR 2.0. Subsequently, we have prepared different simulated data sets of different sample sizes (from 10 to 100 per group/population) and thereafter the power of each test have been calculated individually. The comparative simulated study might lead to formulate robust and comprehensive judgements about the performance of each test in the basis of assumption of data distribution. Finally, a list of advantages and limitations of the different statistical tests has been provided, along with indications of some areas where further studies are required.

Background: Lung cancer is the second most common cancer worldwide, with over two million new cases per year. Early identification would allow healthcare practitioners to handle it more effectively. The advancement of computer-aided detection systems significantly impacted clinical analysis and decision-making on human disease. Towards this, machine learning and deep learning techniques are successfully being applied. Due to several advantages, transfer learning has become popular for disease detection based on image data. Methods: In this work, we build a novel transfer learning model (VER-Net) by stacking three different transfer learning models to detect lung cancer using lung CT scan images. The model is trained to map the CT scan images with four lung cancer classes. Various measures, such as image preprocessing, data augmentation, and hyperparameter tuning, are taken to improve the efficacy of VER-Net. All the models are trained and evaluated using multiclass classifications chest CT images. Results: The experimental results confirm that VER-Net outperformed the other eight transfer learning models compared with. VER-Net scored 91%, 92%, 91%, and 91.3% when tested for accuracy, precision, recall, and F1-score, respectively. Compared to the state-of-the-art, VER-Net has better accuracy. Conclusion: VER-Net is not only effectively used for lung cancer detection but may also be useful for other diseases for which CT scan images are available.